MedElevator
Войти в исследования The journal of prevention of Alzheimer's disease · 2026
Cerebral microhemorrhage and cognition in preclinical Alzheimer's disease.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Baldaranov Dobri, Wang Shunran, Raman Rema, Ernstrom Karin, Kantarci Kejal, Jack Clifford R, Sperling Reisa A, Aisen Paul S, Rafii Michael S
Аннотация
BACKGROUND: Clarifying whether incident cerebral microhemorrhages (CMHs) contribute to early cognitive or functional decline is increasingly important in the context of anti-amyloid therapies.
OBJECTIVE: To determine whether incident CMHs are associated with longitudinal changes in cognition and function in cognitively unimpaired individuals with elevated cerebral amyloid.
DESIGN, SETTING, AND PARTICIPANTS: Post hoc analysis of individuals enrolled in the A4 study. Participants underwent serial MRI and cognitive assessments. Natural cubic spline models adjusted for baseline amyloid PET burden, age, sex, education, and APOE ε4 status.
MEASUREMENTS: Longitudinal change in the Preclinical Alzheimer Cognitive Composite (PACC), Clinical Dementia Rating-Sum of Boxes (CDR-SB), Cognitive Function Index (CFI), and Activities of Daily Living.
RESULTS: Participants who developed ≥2 incident CMHs demonstrated greater longitudinal worsening in CDR-SB (estimate = 0.44; 95% CI, 0.09-0.80; P = .009) and CFI (estimate = 1.37; 95% CI, 0.11-2.60; P = .03), but not in PACC or ADCS ADL.
CONCLUSIONS: Incident CMH accumulation was associated with greater longitudinal worsening in global clinical status and participant-reported functional change, but not objective cognitive performance, among cognitively unimpaired individuals with elevated cerebral amyloid.
OBJECTIVE: To determine whether incident CMHs are associated with longitudinal changes in cognition and function in cognitively unimpaired individuals with elevated cerebral amyloid.
DESIGN, SETTING, AND PARTICIPANTS: Post hoc analysis of individuals enrolled in the A4 study. Participants underwent serial MRI and cognitive assessments. Natural cubic spline models adjusted for baseline amyloid PET burden, age, sex, education, and APOE ε4 status.
MEASUREMENTS: Longitudinal change in the Preclinical Alzheimer Cognitive Composite (PACC), Clinical Dementia Rating-Sum of Boxes (CDR-SB), Cognitive Function Index (CFI), and Activities of Daily Living.
RESULTS: Participants who developed ≥2 incident CMHs demonstrated greater longitudinal worsening in CDR-SB (estimate = 0.44; 95% CI, 0.09-0.80; P = .009) and CFI (estimate = 1.37; 95% CI, 0.11-2.60; P = .03), but not in PACC or ADCS ADL.
CONCLUSIONS: Incident CMH accumulation was associated with greater longitudinal worsening in global clinical status and participant-reported functional change, but not objective cognitive performance, among cognitively unimpaired individuals with elevated cerebral amyloid.